X-Energy Shares Plunge 19% Due to Delays and Downgrade
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 27 2026
0mins
Source: Fool
- Significant Stock Decline: X-Energy's shares fell 19% this week, bringing its market cap to $7.5 billion, reflecting investor concerns about its future amid ongoing challenges since its April IPO.
- Project Delays Impact: The lack of U.S. government approval for X-Energy's reactor designs has delayed the groundbreaking of its first project with Amazon until 2027, directly affecting the company's business outlook.
- Analyst Downgrade: Jeffries downgraded X-Energy's stock from $30 to $22, exacerbating investor panic and leading to a sharp decline in share prices.
- Lack of Actual Business: Despite a market cap of $7.7 billion, X-Energy has minimal revenue, prompting investors to carefully consider whether to buy the stock under current circumstances.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy XE?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on XE
Wall Street analysts forecast XE stock price to rise
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 18.320
Low
Averages
High
Current: 18.320
Low
Averages
High
About XE
X-Energy, Inc. is a designer of advanced nuclear reactor technology and manufacturer of advanced nuclear fuels. The Company’s flagship product, the Xe-100, an advanced small modular high-temperature gas-cooled reactor (HTGR), in development for nearly a decade. The Xe-100 reactor is designed to generate 80 megawatts of electric power or 200 megawatts of thermal output (heat), or a combination thereof. The Xe-100 has several technological attributes, such as advanced safety features, virtually no direct GHG emissions during generation, high thermal output, load-following capabilities and modularity, all of which allow it to more specifically meet a customer’s power and/or industrial heat needs. Its Xe-100 design directly translates into simplicity of project delivery through reduced supply chain complexity and labor intensity during construction, which lead to lower costs and faster deployment timelines when compared with conventional nuclear energy sources.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Stock Performance Decline: Since its April debut, X-Energy (XE) stock has fallen approximately 43%, losing 54% from its peak of $37.10, indicating market concerns over its future profitability, which may impact investor confidence.
- Revenue Reliance on Government: About 82% of the company's revenue is derived from government funding, particularly from the U.S. Department of Energy's project support, which, while providing short-term financial security, may limit its long-term market expansion capabilities.
- Strong Development Pipeline: As of March 31, X-Energy's development pipeline includes 144 reactors across the U.S. and U.K., representing approximately 11.5 gigawatts of potential generating capacity, showcasing the company's long-term growth potential in the nuclear energy market.
- Analysts Optimistic on Outlook: Despite the stock's decline, Wall Street analysts have set an average 12-month price target of $37.86 for XE, with six analysts rating it as a 'Buy', indicating confidence in its potential rebound.
See More
- IPO Market Recovery: The IPO market rebounded quickly in Q2, with 48 companies raising a record $104.8 billion, indicating a strong recovery and renewed investor confidence following the volatility of Q1.
- Record Financing by SpaceX: SpaceX raised $75 billion in its IPO, surpassing the total amount raised by all US IPOs in the previous two years combined, highlighting its significant influence and appeal in the capital markets.
- Significant Market Capitalization: At listing, SpaceX commanded a market cap of $1.7 trillion, immediately making it one of the largest public companies on US exchanges, reflecting its leadership position and growth potential in the aerospace sector.
- Strong Overall Market Performance: Even without SpaceX's IPO, Q2 would have seen the highest IPO proceeds since 2021, driven by a steady influx of large deals, further enhancing market activity.
See More
- Significant Stock Decline: X-Energy's shares fell 19% this week, bringing its market cap to $7.5 billion, reflecting investor concerns about its future amid ongoing challenges since its April IPO.
- Project Delays Impact: The lack of U.S. government approval for X-Energy's reactor designs has delayed the groundbreaking of its first project with Amazon until 2027, directly affecting the company's business outlook.
- Analyst Downgrade: Jeffries downgraded X-Energy's stock from $30 to $22, exacerbating investor panic and leading to a sharp decline in share prices.
- Lack of Actual Business: Despite a market cap of $7.7 billion, X-Energy has minimal revenue, prompting investors to carefully consider whether to buy the stock under current circumstances.
See More
- Project Delays Impact: X-Energy's reactor design lacks official approval from the U.S. government, causing delays in its first project with Amazon until 2027, which negatively affects the company's growth prospects and investor confidence.
- Analyst Downgrade: Jefferies downgraded X-Energy's stock from $30 to $22, resulting in a 19% drop in shares this week, reflecting market concerns about its future profitability.
- Poor Revenue Situation: Despite a market cap of $7.7 billion, X-Energy currently generates almost no revenue, indicating the fragility of its business model and potentially leading investors to be cautious about future returns.
- Massive Funding Needs: To secure reactor design approvals and establish manufacturing facilities, X-Energy will require substantial upfront capital, which will further strain its finances and limit its competitiveness in the nuclear energy market.
See More

- Profit Surge: Jefferies reported a profit of $226.2 million in Q2, translating to $1.02 per share, a significant increase from $88 million or $0.40 per share a year ago, indicating robust performance in investment banking.
- Advisory Revenue Boom: Advisory revenue surged 47% to a record $674.1 million, while investment banking net revenues jumped 57.5% year-over-year to $1.21 billion, reflecting strong demand for M&A advisory services in the current market.
- Equity Market Activity: Equity underwriting revenue exceeded $370.7 million in the quarter, more than tripling year-over-year, with Jefferies acting as joint global coordinator on Galderma's $6.3 billion share sale, marking the largest sponsor-backed block trade in history.
- Trading Revenue Growth: Jefferies' capital markets business posted $799.3 million in revenue, up 13.5% from last year, with equities trading revenue rising 14% to a record $600.8 million, highlighting a trend of investors adjusting portfolios amid market volatility.
See More
- Market Recovery: The IPO market rebounded quickly in Q2, with 48 companies going public and raising a record $104.9 billion, indicating a resurgence of market confidence.
- SpaceX's Major Deal: SpaceX raised $75 billion in its IPO, surpassing the total of all US IPOs from the previous two years combined, achieving a market cap of $1.7 trillion at listing, making it one of the largest public companies on US exchanges.
- Strong First Day Performance: SpaceX's stock rose 19% on its debut, alleviating concerns about an overly hot or cold opening, although aftermarket trading remained volatile.
- Large Deal Momentum: Even without SpaceX's deal, Q2 would have been the largest quarter for IPO proceeds since 2021, with nine other IPOs raising over $1 billion, showcasing the ongoing appeal of large transactions.
See More









